Ausgabe 4/2008
Inhalt (22 Artikel)
Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application
E. Siris, P. D. Delmas
FRAX™ and the assessment of fracture probability in men and women from the UK
J. A. Kanis, O. Johnell, A. Oden, H. Johansson, E. McCloskey
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
S. Fujiwara, T. Nakamura, H. Orimo, T. Hosoi, I. Gorai, A. Oden, H. Johansson, J. A. Kanis
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson, L. J. Melton III, B. Dawson-Hughes, S. Baim, M. J. Favus, S. Khosla, R. L. Lindsay
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
B. Dawson-Hughes, A. N. A. Tosteson, L. J. Melton III, S. Baim, M. J. Favus, S. Khosla, R. L. Lindsay
Absolute fracture risk reporting in clinical practice: A physician-centered survey
W. D. Leslie
Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature
J. D. Vescovi, S. A. Jamal, M. J. De Souza
Salmon calcitonin: a review of current and future therapeutic indications
C. H. Chesnut III, M. Azria, S. Silverman, M. Engelhardt, M. Olson, L. Mindeholm
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)
C. Cooper, F. Jakob, C. Chinn, E. Martin-Mola, P. Fardellone, S. Adami, N. C. Thalassinos, J. Melo-Gomes, D. Torgerson, A. Gibson, F. Marin
Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis
P. Marquis, C. Roux, C. de la Loge, M. Diaz-Curiel, C. Cormier, G. Isaia, J. Badurski, J. Wark, P. J. Meunier
Loss of treatment benefit due to low compliance with bisphosphonate therapy
F. J. A. Penning-van Beest, J. A. Erkens, M. Olson, R. M. C. Herings
Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use
C. M. Wetmore, L. Ichikawa, A. Z. LaCroix, S. M. Ott, D. Scholes
Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy
F. Cosman, J. W. Nieves, M. Zion, N. Barbuto, R. Lindsay
Does thoracic or lumbar spine bone architecture predict vertebral failure strength more accurately than density?
E.-M. Lochmüller, K. Pöschl, L. Würstlin, M. Matsuura, R. Müller, T. M. Link, F. Eckstein
Experimental hip fracture load can be predicted from plain radiography by combined analysis of trabecular bone structure and bone geometry
P. Pulkkinen, T. Jämsä, E.-M. Lochmüller, V. Kuhn, M. T. Nieminen, F. Eckstein
Changes of substance P-immunoreactive nerve fiber innervation density in the sublesional bones in young growing rats at an early stage after spinal cord injury
D. Liu, H. Li, C.-Q. Zhao, L.-S. Jiang, L.-Y. Dai
Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women
B. M. H. Lai, C. L. Cheung, K. D. K. Luk, A. W. C. Kung
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study
A. Papaioannou, C. C. Kennedy, G. Ioannidis, Y. Gao, A. M. Sawka, D. Goltzman, A. Tenenhouse, L. Pickard, W. P. Olszynski, K. S. Davison, S. Kaiser, R. G. Josse, N. Kreiger, D. A. Hanley, J. C. Prior, J. P. Brown, T. Anastassiades, J. D. Adachi
Bone mineral density and mandibular bone quality in patients receiving dental implants: reply to Dr. Taguchi
M. A. L. Amorim